IBM Clinical Trial Management System (CTMS) for Sites, formally known as Merge Clinical Trial Management System for Investigators, is a platform used by institutions conducting research to organize, centralize, and manage clinical research operations and finances across their institution. It supports large hospitals and academic organizations as well as independent research organizations. When implemented as part of the central research infrastructure at clinical research sites, CTMS for Sites helps to streamline the clinical trial process and maximizes operational efficiencies. It is designed to reduce financial compliance risk, increase performance transparency across organizations, maximize revenue or cost coverage, reduce burden of duplicate data entry, and support efficient participant recruitment. CTMS for Sites provides a building block for centralization and standardization at research sites and can help create an end-to-end ecosystem that supports clinical care as well as research, regardless of research specialty or site type.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries. Learn more at www.iqvia.com.
MRN specializes in the conduct of clinical trial visits in the patient’s home and supporting clinical trial sites with nursing resources. We believe in reducing the burden of participation on patients and reducing the burden on participation on sites – building more patient-centric clinical trials.
MRN offers two core services in the management of complex clinical trials:
Home Trial Support (HTS) is the conduct of clinical trial visits in the patient’s home. This replaces a number of protocol defined visits which would normally take place onsite, and relocates them in the patient’s home – reducing the burden of the trial on the patient and significantly boosting patient recruitment and maximizing patient retention. With HTS, sites can recruit patients from a wider geographical region and reach a larger patient pool, as well as increase their consenting and retention rates. We have seen that reducing the burden on patients directly increases recruitment by 60% or more and typically maintains patient retention at over 95%, as well as reducing the burden on clinical sites.
Site Nurse Support (SNS) places experienced research nurses into sites to manage trials; this enables each site to focus on patient identification and selection, as well as facilitating performance of all procedures in a timely manner. Placements can be made at single sites, or nursing teams can be pulled together to support sites across whole countries or trials. With SNS, sites have a dedicated resource to identify and screen patients from the increased patient pool effectively.
Together, the impact of these services can result in an increase of up to 600% of completed patients per site.
MRN is a recognized leader in the Home Trial Support clinical trials field. We have a geographical coverage of over 40 countries where we can provide our services. Headquartered in the UK and with offices in North America and Spain, our Vendor Contracts and Management Team (VCMT) have enabled us to conduct Home Trial support visits across all major clinical research countries spanning North America, Europe, Asia and Australasia
CLiX AI automates the interrogation and structure of patient’s narrative data to give CROs and Sponsors a distinct data-driven advantage at critical points throughout the clinical trial life cycle. With the CLiX accelerate solution it is possible to:
• Increase predictability and reduce risk during bid phase feasibility assessment
• Shorten study start-up time by speeding up subject recruitment
• Automate retrospective information sorting for more accurate risk evaluation and mitigation during post-market surveillance
Ok, that’s about it!
An SCRS Global Impact Partner™
With more than 1,500,000 registered healthcare professionals worldwide, growing at an average of 15,000 – 22,500 new registrants per month, BlueCloud® has the fastest growing networks in healthcare and clinical research. A global networking technology that enables industry stakeholders to create new and efficient business models that improve patient care by implementing standards and eliminating waste and fraud. This ecosystem allows the exchange of “real-time” information required by regulatory agencies. BlueCloud acts as the catalyst for standardizing global programs like the NIH Stroke Scale (NIHSS), Modified Rankin mRS, Barthel Index (BI), Suicidality Scale (C-SSRS) and other diagnostic neuroscience programs. Let’s save lives, together!”.
For more information visit www.healthcarepoint.com
Revolutionizing Clinical Trials
Founded in 2007, Clinical Ink is the pioneering provider of eSource solutions for clinical trials. Developers of SureSource® — the first purpose-built and most widely used eSource plaftform — Clinical Ink is dedicated to streamlining clinical development from Start to Submit™.
Ideal for every phase of clinical development, SureSource makes clinical research easier for sites, sponsors, subjects and regulators. As the only purpose-built solution that meets all regulatory requirements for eSource, SureSource was developed from the beginning to streamline clinical research — by experts in the fields of clinical investigations and medical forms publishing.
Discover how Clinical Ink’s SureSource platform can speed data access to dramatically reduce clinical trial costs and timelines.
